Eiki Ichihara

Eiki Ichihara

UNVERIFIED PROFILE

Are you Eiki Ichihara?   Register this Author

Register author
Eiki Ichihara

Eiki Ichihara

Publications by authors named "Eiki Ichihara"

Are you Eiki Ichihara?   Register this Author

77Publications

1613Reads

23Profile Views

Managing Lung Cancer with Comorbid Interstitial Pneumonia.

Intern Med 2019 Sep 18. Epub 2019 Sep 18.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.3481-19DOI Listing
September 2019

Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma.

J Thorac Oncol 2019 Aug;14(8):e168-e169

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.009DOI Listing
August 2019

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer.

Lung Cancer 2019 Jun 6;132:54-58. Epub 2019 Apr 6.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.02.021DOI Listing
June 2019

Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutation.

Jpn J Clin Oncol 2019 Jun 12. Epub 2019 Jun 12.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyz086DOI Listing
June 2019

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice.

Int J Clin Oncol 2019 Jan 29;24(1):41-45. Epub 2018 Aug 29.

Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-018-1344-xDOI Listing
January 2019

Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells.

Acta Med Okayama 2017 12;71(6):505-512

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/55587DOI Listing
December 2017

Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation.

Acta Med Okayama 2016 Aug;70(4):243-53

Department of Haematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/54499DOI Listing
August 2016

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Cancer Discov 2016 06 21;6(6):601-11. Epub 2016 Apr 21.

Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Addario Lung Cancer Medical Institute, Cambridge, Massachusetts. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893907PMC
June 2016

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients with Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Aug;10(8):e79

Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000583DOI Listing
August 2015

Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer.

Cancer Discov 2015 Jul;5(7):694-6

Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-15-0616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499857PMC
July 2015

Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

J Thorac Oncol 2015 Mar;10(3):486-91

*Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; †Department of Hematology/Oncology, Vanderbilt Vanderbilt University Medical Center, Nashville, TN; ‡Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan; §Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan; ‖Department of Medical Oncology, NHO Yamaguchi-Ube Medical Center, Ube, Japan; ¶Department of Respiratory Internal Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan; #Division of Clinical Oncology, Sumitomo Besshi Hospital, Niihama, Japan; **Department of Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, Japan; ††Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan; ‡‡Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan; and §§Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000434DOI Listing
March 2015

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.

Jpn J Clin Oncol 2014 Oct 28;44(10):963-8. Epub 2014 Aug 28.

Department of Allergy and Respiratory Medicine (Thoracic Oncology), Okayama University Hospital, Okayama, Japan

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyu110DOI Listing
October 2014

Everolimus prolonged survival in transgenic mice with EGFR-driven lung tumors.

Exp Cell Res 2014 Aug 25;326(2):201-9. Epub 2014 Apr 25.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama, University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144827140017
Publisher Site
http://dx.doi.org/10.1016/j.yexcr.2014.04.012DOI Listing
August 2014

Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer.

Exp Cell Res 2014 Mar 15;322(1):168-77. Epub 2014 Jan 15.

Department of Respiratory Medicine, Okayama University Hospital, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00144827140001
Publisher Site
http://dx.doi.org/10.1016/j.yexcr.2014.01.007DOI Listing
March 2014

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model.

Lung Cancer 2014 Jan 29;83(1):30-6. Epub 2013 Oct 29.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.10.011DOI Listing
January 2014

Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model.

Cancer Sci 2013 Nov 25;104(11):1440-6. Epub 2013 Oct 25.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12284DOI Listing
November 2013

Antitumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers.

Mol Cancer Ther 2013 Aug 12;12(8):1616-28. Epub 2013 Jun 12.

Division of Oncological Pathology, Aichi Cancer Center Research Institute, Chikusa-ku, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-1239DOI Listing
August 2013

A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome.

Intern Med 2013 1;52(1):97-100. Epub 2013 Jan 1.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.52.7882DOI Listing
July 2013

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model.

Mol Cancer Ther 2013 May 26;12(5):589-97. Epub 2013 Feb 26.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0885DOI Listing
May 2013

Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells.

Mol Cancer Res 2013 Feb 13;11(2):140-8. Epub 2012 Dec 13.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical ciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/cgi/doi/10.1158/1541-7786.MCR-12
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-12-0401DOI Listing
February 2013

Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiency.

Exp Cell Res 2013 Feb 27;319(4):417-23. Epub 2012 Dec 27.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2012.12.018DOI Listing
February 2013

Favorable response of heavily treated Wilms' tumor to paclitaxel and carboplatin.

Onkologie 2012 24;35(5):283-6. Epub 2012 Apr 24.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000338532DOI Listing
January 2013

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.

Cancer Sci 2013 Jan 24;104(1):78-84. Epub 2012 Nov 24.

Department of Hematology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12045DOI Listing
January 2013

JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation.

Cancer Sci 2012 Oct 24;103(10):1795-802. Epub 2012 Jul 24.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2012.02363.xDOI Listing
October 2012

[Case report: Two cases of adult Langerhans cell histiocytosis treated with systemic chemotherapy].

Nihon Naika Gakkai Zasshi 2012 May;101(5):1386-8

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/naika.101.1386DOI Listing
May 2012

Targeting angiogenesis in cancer therapy.

Acta Med Okayama 2011 Dec;65(6):353-62

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/47260DOI Listing
December 2011

Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.

Cancer Lett 2011 Oct 24;309(2):228-35. Epub 2011 Jun 24.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.06.006DOI Listing
October 2011

Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells.

Mol Cancer Ther 2011 Sep 28;10(9):1720-7. Epub 2011 Jun 28.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-11-0220DOI Listing
September 2011

Early palliative care in non-small-cell lung cancer.

N Engl J Med 2010 12;363(23):2263; author reply 2264-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1010529DOI Listing
December 2010

Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.

Cancer Res 2009 Sep 18;69(17):7088-95. Epub 2009 Aug 18.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4205DOI Listing
September 2009

Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo.

Cancer Res 2009 Jun 2;69(12):5091-8. Epub 2009 Jun 2.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/69/12/5091.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-08-4204DOI Listing
June 2009

Pseudoprogression of lung cancer after concomitant chemoradiotherapy.

Jpn J Clin Oncol 2008 Feb 1;38(2):140-2. Epub 2008 Feb 1.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata, Okayama, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hym166DOI Listing
February 2008

[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].

Nihon Kokyuki Gakkai Zasshi 2007 Oct;45(10):808-11

Department of Respiratory Medicine, Okayama University School of Medicine.

View Article

Download full-text PDF

Source
October 2007

[Azygos vein aneurysm occurring simultaneously with hemoptysis].

Nihon Kokyuki Gakkai Zasshi 2007 Jun;45(6):479-82

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine.

View Article

Download full-text PDF

Source
June 2007